KeyZell
Biopharmaceutical company in clinical stage focused on the development of targeted anticancer compounds.
KeyZell is a company in biotechnology, health diagnostics, product research based in European Union (EU), Europe, Middle East, and Africa (EMEA), founded in 2020.
KeyZell is positioned in biotechnology, health diagnostics, product research, a segment that rewards a clear, focused offering.
The business is associated with European Union (EU), Europe, Middle East, and Africa (EMEA).
The company is listed at the Private company stage of development.
Its team size is recorded as c_00011_00050 employees.
| Sector | Biotechnology, Health Diagnostics, Product Research |
|---|---|
| Headquarters | European Union (EU), Europe, Middle East, and Africa (EMEA) |
| Founded | 2020 |
| Employees | c_00011_00050 |
| Stage | Private company |
Website: keyzell.com/en
Browse related
Emails and contact routes are reserved for registered members.
Create a free account
Create a free account